BIG DATA: SECURITY ISSUES, CHALLENGES AND FUTURE SCOPE

whitePaper | June 3, 2022

Analyzing data has been a unique business activity for at least 5,000 years, and possibly as long ago as 20,000 years. We have come a long way in how we count, summarize, analyze, predict, and prescribe upcoming courses of action in science, business, and all fields of human endeavor. In the past 75 years, the progress in how we analyze data has increased exponentially. We now regularly build analytical models and complete applications that analyze massive amounts of data.

whitePaper | May 1, 2023

This document is intended to provide a high-level overview of the proposed data architecture for PulseNet 2.0. If the details come across as vague, that merely reflects where we are in the development phase. Further questions are welcome and can be directed to pulsenet@cdc.gov with “PulseNet 2.0” in the subject line.

whitePaper | November 15, 2019

The potential of artificial intelligence to transform business performance is only now starting to be more widely understood in Financial Services. This is nowhere clearer than in the security domain, where the fusion of big data, advanced analytics and machine learning holds out the promise of startling improvements in cyber defenses through the introduction of Prescriptive Security.

whitePaper | October 20, 2022

Data governance defines how data should be gathered and used within an organization. Download this whitepaper to understand how it's linked to business success.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | August 25, 2022

Everyday user experiences are being completely reimagined. Requesting a ride through an app is better than calling a cab. Buying online is changing the way we go shopping. And gone are the days of waiting in long lines at your local bank. Data within these modern businesses is in constant motion, flowing, in real-time, across systems, environments, and applications every time a user interacts with the system.